Cancer Immunotherapy in India
India offers the full spectrum of cancer immunotherapy including PD-1/PD-L1 checkpoint inhibitors (Pembrolizumab, Nivolumab), CTLA-4 inhibitors (Ipilimumab), and CAR-T cell therapy — with biosimilar versions dramatically reducing costs vs the USA.
Check Your Eligibility — Free
Send your reports. Our specialists will review and confirm whether Immunotherapy is right for your case.
📋 Get Free Assessment| Cost Comparison | India | USA |
|---|---|---|
| Immunotherapy | $800–$2,500 per cycle | $10,000–$15,000 per cycle |
| Savings | 60–80% less than USA | |
Conditions Treated with Immunotherapy
- Lung cancer (Pembrolizumab for PD-L1 ≥50%)
- Melanoma (Nivolumab + Ipilimumab)
- Head and neck cancer (Pembrolizumab, Nivolumab)
- Bladder cancer (Atezolizumab, Pembrolizumab)
- Colorectal cancer (Pembrolizumab for MSI-H)
- Gastric cancer (Nivolumab)
- Leukaemia/Lymphoma (CAR-T cell therapy)
How Immunotherapy Works (Step by Step)
- PD-L1, MSI/MMR, TMB biomarker testing
- Oncologist review of immunotherapy eligibility
- Baseline organ function and autoimmune history review
- IV infusion (30–60 min) every 2–6 weeks
- Clinical and imaging response assessment (8–12 weeks)
- Immune-related adverse event (irAE) monitoring
- Continued until progression or unacceptable toxicity
Benefits of Immunotherapy in India
- Durable responses lasting years in some patients
- Less nausea and hair loss than chemotherapy
- Biosimilars available at 60–70% lower cost
- Response rates: 20–45% across tumour types
- Combination regimens available (dual checkpoint, chemo-immuno)
Best Hospitals for Immunotherapy in India
- Tata Memorial Hospital, Mumbai
- Apollo Cancer Centre, Chennai
- AIIMS, New Delhi
- Rajiv Gandhi Cancer Institute, Delhi
- HCG Oncology, Bangalore
Frequently Asked Questions
Q: How much does Pembrolizumab (Keytruda) cost in India?
A: Pembrolizumab costs $800–$1,200 per cycle (200mg) in India using biosimilars vs $10,000–$12,000 per cycle in the USA. A full year of treatment costs $20,000–$30,000 in India vs $120,000–$150,000 in the USA.
Q: Is CAR-T cell therapy available in India?
A: Yes. CAR-T therapy (Kymriah equivalent) is available at select Indian centres including AIIMS (Delhi) and Tata Medical Center (Kolkata). Cost in India: $40,000–$60,000 vs $350,000–$500,000 in the USA.